Benefits of surgery for lung cancer unclear

NEW YORK (Reuters Health) - Evidence from clinical trials neither supports nor refutes a benefit for surgery as a treatment for the most common type of lung cancer, non-small cell lung cancer or NSCLC, according to findings from the first-ever systematic review to address this topic.

Continue to Benefits of surgery for lung cancer unclear on Reuters: Health.

Medical Buzz delivers the most recent headlines from the medical world. Diseases, cures, accidents, medicin. Click below for more headlines ...
Medical buzz